For the year ending 2025-12-31, LPCN made $1,976.677K in revenue. -$9,632.198K in net income. Net profit margin of -487.29%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 1,976.677 | |||
| Research and development | 8,583.919 | |||
| General and administrative | 3,764.137 | |||
| Total operating expenses | 12,348.056 | |||
| Operating loss | -10,371.379 | |||
| Interest and investment income | 744.074 | |||
| Total other income | 744.074 | |||
| Income (loss) before income tax expense | -9,627.305 | |||
| Income tax expense | 0.2 | |||
| Net income (loss) | -9,627.505 | |||
| Net unrealized gain (loss) on available-for-sale securities | -4.693 | |||
| Comprehensive gain (loss) | -9,632.198 | |||
| Basic EPS | -1.77 | |||
| Diluted EPS | -1.69 | |||
| Basic Average Shares | 5,448,871 | |||
| Diluted Average Shares | 5,708,238 | |||
Lipocine Inc. (LPCN)
Lipocine Inc. (LPCN)